search
Back to results

Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial.

Primary Purpose

Temporomandibular Joint Dysfunction Syndrome, Tooth Injuries, Dental Occlusion, Traumatic

Status
Terminated
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Solubrux®
Customized Appliance
Somatics®
Sponsored by
Eva Willaert Jiménez-Pajarero
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Temporomandibular Joint Dysfunction Syndrome

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients should have an intellectual level that allows a proper communication and must agree to cooperate in all tests and exams required by the study protocol.
  • Obtaining written informed consent for participating in the project (model consent form)
  • The patient must have enough teeth in the upper arch or being a carrier of a stable removable prosthesis.

Exclusion Criteria:

  • Being in a maintenance ECT program.
  • Receiving ECT during the six months prior to the index episode.
  • Pregnancy and lactation.

Sites / Locations

  • Hospital Universitari de Bellvitge

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Sequence SB-CA-SM

Sequence SB-SM-CA

Sequence CA-SB-SM

Sequence CA-SM-SB

Sequence SM-SB-CA

Sequence SM-CA-SB

Arm Description

Solubrux®+ Customized Appliance + Somatics®

Solubrux®+Somatics®+Customized Appliance

Customized Appliance+Solubrux®+Somatics®

Customized Appliance+Somatics®+Solubrux®

Somatics®+Solubrux®+Customized Appliance

Somatics®+ Customized Appliance+Solubrux®

Outcomes

Primary Outcome Measures

temporomandibular pain
Continuous quantitative variable assessed by visual analogue scale (VAS) of 100 mm in length, marking the end as no pain (source) or the worst pain imaginable (final)

Secondary Outcome Measures

Dental fractures
Dichotomic qualitative variable assessed by inspection: 0= 0 fractures; 1=≥1 fractures
Dental mobility assessed by Periotest®
Continuous quantitative /qualitative ordinal assessed by an electronic instrument that uses an ultrasonically vibrating probe (Periotest®) to assess dental mobility.
Oral soft tissues injuries
Dichotomic qualitative variable assessed by inspection: 0= 0 lesions; 1=≥1 lesions

Full Information

First Posted
January 25, 2016
Last Updated
May 17, 2022
Sponsor
Eva Willaert Jiménez-Pajarero
search

1. Study Identification

Unique Protocol Identification Number
NCT02678715
Brief Title
Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial.
Official Title
Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Terminated
Why Stopped
Recruitment period too long
Study Start Date
February 2016 (undefined)
Primary Completion Date
May 2022 (Actual)
Study Completion Date
May 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Eva Willaert Jiménez-Pajarero

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This observer-blind crossover intervention study aims to determine the most effective type of device as oral mouthguard in modified-Electroconvulsive Therapy (m-ECT) comparing three types of devices: standard, prefabricated and manufactured in the dental laboratory. Patients from the ECT Unit of Psychiatric Department of the University Hospital of Bellvitge will use the three devices at a random sequence during the twelve treatment sessions, so each device (A, B, C) will be used for two weeks, that is, for four consecutive sessions.
Detailed Description
Treatment with electroconvulsive therapy will involve the application of 12 m-ECT sessions at the rate of two sessions for six weeks according to the protocol established in the ECT Unit of the Department of Psychiatry at the University Hospital of Bellvitge. Two devices, SB and CA, will be prepared for each patient and placed in mouth before anesthesia by one operator. This operator will assign a randomized sequence of use of the three devices (SB, CA or SM). Device SM will be the sole protector that will be placed after the anesthesia by nurse. The outcome assessor will the scans pre- and post-session m-ECT and collect data, accede the surgery room before the session with the patient conscious and perform the exploration. This outcome assessor will leave the operating room during the procedure for the application of m-ECT an come back an hour later for the post-examination session.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Temporomandibular Joint Dysfunction Syndrome, Tooth Injuries, Dental Occlusion, Traumatic

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sequence SB-CA-SM
Arm Type
Experimental
Arm Description
Solubrux®+ Customized Appliance + Somatics®
Arm Title
Sequence SB-SM-CA
Arm Type
Experimental
Arm Description
Solubrux®+Somatics®+Customized Appliance
Arm Title
Sequence CA-SB-SM
Arm Type
Experimental
Arm Description
Customized Appliance+Solubrux®+Somatics®
Arm Title
Sequence CA-SM-SB
Arm Type
Experimental
Arm Description
Customized Appliance+Somatics®+Solubrux®
Arm Title
Sequence SM-SB-CA
Arm Type
Experimental
Arm Description
Somatics®+Solubrux®+Customized Appliance
Arm Title
Sequence SM-CA-SB
Arm Type
Experimental
Arm Description
Somatics®+ Customized Appliance+Solubrux®
Intervention Type
Device
Intervention Name(s)
Solubrux®
Intervention Description
prefabricated device adaptable by temperature
Intervention Type
Device
Intervention Name(s)
Customized Appliance
Intervention Description
customized device fabricated in the dental laboratory
Intervention Type
Device
Intervention Name(s)
Somatics®
Intervention Description
standard device
Primary Outcome Measure Information:
Title
temporomandibular pain
Description
Continuous quantitative variable assessed by visual analogue scale (VAS) of 100 mm in length, marking the end as no pain (source) or the worst pain imaginable (final)
Time Frame
through study completion, an average of six weeks
Secondary Outcome Measure Information:
Title
Dental fractures
Description
Dichotomic qualitative variable assessed by inspection: 0= 0 fractures; 1=≥1 fractures
Time Frame
through study completion, an average of six weeks
Title
Dental mobility assessed by Periotest®
Description
Continuous quantitative /qualitative ordinal assessed by an electronic instrument that uses an ultrasonically vibrating probe (Periotest®) to assess dental mobility.
Time Frame
through study completion, an average of six weeks
Title
Oral soft tissues injuries
Description
Dichotomic qualitative variable assessed by inspection: 0= 0 lesions; 1=≥1 lesions
Time Frame
through study completion, an average of six weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients should have an intellectual level that allows a proper communication and must agree to cooperate in all tests and exams required by the study protocol. Obtaining written informed consent for participating in the project (model consent form) The patient must have enough teeth in the upper arch or being a carrier of a stable removable prosthesis. Exclusion Criteria: Being in a maintenance ECT program. Receiving ECT during the six months prior to the index episode. Pregnancy and lactation.
Facility Information:
Facility Name
Hospital Universitari de Bellvitge
City
L'Hospitalet de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08907
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial.

We'll reach out to this number within 24 hrs